https://www.selleckchem.com/pr....oducts/epz004777.htm
The median survival as of last follow-up of all patients was 350 days. Pre- and postprocedure New York Heart Association (NYHA) class data were available in 11 of 24 patients; of these 11 patients, 72.7% improved at least 1 NYHA class from baseline. CAVI may be performed safely in a high surgical risk population with severe tricuspid regurgitation. Dedicated studies with longer-term follow-up are needed. CAVI may be performed safely in a high surgical risk population with severe tricuspid regurgitation. Dedicated studies with longer-t
إعجاب
علق
شارك
